首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain.
【24h】

Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain.

机译:不育和骨盆疼痛的子宫内膜异位症妇女的白细胞介素1及其诱饵抑制受体II型腹膜水平失衡。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To evaluate the levels of interleukin-1beta (IL1beta) and its inhibitory soluble interleukin-1 receptor type II (IL1R2) in the peritoneal fluid (PF) of normal women and patients with endometriosis suffering from pelvic pain and infertility. DESIGN: Retrospective study using ELISA to measure peritoneal fluid IL1beta and soluble IL1R2. SETTING: Gynecology clinic and human reproduction research laboratory. PATIENT(S): Sixty-eight normal women and 154 women with endometriosis. INTERVENTION(S): Peritoneal fluid samples were obtained at laparoscopy. MAIN OUTCOME MEASURE(S): IL1beta and soluble IL1R2 concentrations in the PF samples. RESULT(S): This study showed a marked decrease in peritoneal soluble IL1R2 levels in women with endometriosis compared to normal women and a concomitant increase in the levels of IL1beta. Both fertile and infertile women with endometriosis had lower soluble IL1R2 and higher IL1beta concentrations than fertile women having a normal gynecological status, but the difference was more significant in infertile endometriosis patients. Compared with normal controls, the decrease in soluble IL1R2 levels was less significant in women with endometriosis than without pelvic pain, whereas the increase in IL1beta concentrations was statistically significant only in women with endometriosis reporting pelvic pain. CONCLUSION(S): This study revealed an imbalance between IL1beta and its decoy inhibitory receptor type 2 in women with endometriosis, which was particularly obvious in those who were infertile, and suggests that a defect in the local control of IL1 may be involved in the pathophysiology of endometriosis and related infertility.
机译:目的:评估正常妇女和患有盆腔疼痛和不孕症的子宫内膜异位患者腹膜液(PF)中白细胞介素-1β(IL1beta)及其抑制性可溶性白细胞介素-1受体II型(IL1R2)的水平。设计:回顾性研究,使用ELISA法测量腹膜液IL1beta和可溶性IL1R2。地点:妇科诊所和人类生殖研究实验室。患者:68名正常女性和154名子宫内膜异位女性。干预:腹腔镜检查获得腹膜液样品。主要观察指标:PF样品中IL1beta和可溶性IL1R2浓度。结果:这项研究显示,与正常女性相比,子宫内膜异位症女性的腹膜可溶性IL1R2水平显着降低,并且IL1beta水平随之升高。与具有正常妇科状况的可育女性相比,患有子宫内膜异位的可育和不育女性均具有较低的可溶性IL1R2和较高的IL1β浓度,但在不育性子宫内膜异位患者中差异更为显着。与正常对照组相比,子宫内膜异位症患者的可溶性IL1R2水平降低比没有骨盆痛的女性明显降低,而IL1β浓度的升高仅在子宫内膜异位症患者报告有骨盆痛的情况下具有统计学意义。结论:该研究显示子宫内膜异位症妇女IL1β及其诱饵抑制受体2型之间不平衡,这在不育症患者中尤为明显,并提示IL1的局部控制缺陷可能与子宫内膜异位症有关。子宫内膜异位症的病理生理学及相关的不孕症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号